Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less ...

The ZENITH study found that in high-risk PAH, add-on sotatercept was tied to lower risk for death from any cause, lung ...

Shares of Insmed Incorporated (INSM) soared 25% in Tuesday’s pre-market after the company announced positive results from a ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Shares of Insmed rose after the company disclosed what it called positive topline results from a study of its treatment for pulmonary arterial hypertension, or high blood pressure in the lungs. The ...

Adding more lines of treatment may reduce the risk of rehospitalization among adults with PAH who are taking only one ...

In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...